IN VIVO ANTI-DIABETIC ACTIVITY EVALUATION OF THE BARK OF CASCABELA THEVETIA L. IN STREPTOZOTOCIN INDUCED DIABETIC RATS
DOI:
https://doi.org/10.22159/ijpps.2017v9i6.17200Keywords:
Antidiabetic activity, Cascabela thevetia L, Streptozotocin, Type 2 diabetes, In vivo studyAbstract
Objective: In this study, the plant Cascabela thevetia L. was selected based on ethnomedicinal documentation reports for evaluation of the antidiabetic activity. The aim of this study was to carry out acute toxicity study and in vivo evaluation of antidiabetic activity in an animal model.
Methods: Firstly direct extraction of the dried bark powder was done with methanol using soxhlet apparatus. After collecting the extract, acute toxicity study was performed according to OECD (Organization for Economic Cooperation and Development) guideline 425. For in vivo evaluation of antidiabetic activity, streptozotocin (STZ) and nicotinamide induced type 2 diabetic male rat model was used. Six groups containing six animals in each were taken for the in vivo study and marked as normal control, standard control, negative control and test controls. For all the animals body weight, body temperature, blood glucose levels were determined at an interval of 5 d. After 15 d of treatment different biochemical parameters like triglyceride, cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), alkaline phosphatase level (ALP), serum glutamic oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), total protein were determined and the results were evaluated by statistically using one-way analysis of variance (ANOVA). On the 15th day, all the animals were sacrificed and histopathological study of pancreases tissue was done.
Results: The effects of the test extracts in lowering the blood glucose level and maintaining other biochemical parameters in the test groups were compared with the effect of standard drug metformin hydrochloride, 10 mg/kg body weight treated group and negative control group. The data were statistically evaluated using one-way analysis of variance (ANOVA) followed by Dunnet comparison all vs control method and taking significant at p<0.01. By comparing different biochemical parameters and histoarchitecture of the different test groups of animals, it was found that group V treated with 200 mg/kg body weight shows a significant effect.
Conclusion: After performing the experiment it was found that the bark of Cascabela thevetia L. has the potential for blood glucose lowering activity and able to control abnormal lipids and enzymes level in blood. Further isolation of the compounds can lead to finding out the exact compound responsible for the activity.
Â
Downloads
References
Barcelo A, Rajpathak S. Incidence, and prevalence of diabetes mellitus in the America. Am J Public Health 2001;10:300-8.
Luzi L. Pancreas transplantation and diabetic complications. N Engl J Med 1998;339:115-7.
Gilman AG, Goodman LS. The pharmacological basis of therapeutics. 5th ed. New York: Macmillan; 1985.
Spiller HA, Sawyer TS. Toxicology of oral antidiabetic medications. Am J Health Syst Pharm 2006;63:929-38.
WHO Expert Committee on Diabetes Mellitus: second report. World Health Organ Tech Rep Ser 1980;646:1-80.
Saravanamuttu S, Sudarsanam D. Antidiabetic plants and their active ingredients: a review. Int J Pharm Sci Res 2012;3:3639-50.
Khan MH, Yadava PS. Antidiabetic plants used in thoubal district of Manipur, North-East India. Indian J Tradit Know 2010;9:510-4.
Srivastava N, Chauhan AS, Sharma B. Isolation and characterization of some phytochemicals from indian traditional plants. Biotechnol Res Int 2012;1-8. http:// dx.doi.org/10.1155/2012/549850
Deshmukh V, Zade Z. Antifertility effect of aqueous, alcoholic and petroleum ether extract of Cascabela thevetia L. Fruit in female albino rats. Int J Pharm Biol Arch 2014;5:60-6.
Masiello P, Broca C, Gross R, Roye M, Manteghetti HD, Novelli RG. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998;47:224-9.
Rees DA, Alcolado JC. Animal models for diabetes mellitus. Diabet Med 2005;22:359-70.
Selvan VT, Manikandan L, Kumar SGP, Suresh R, Kakoti BB, Gomathi P, et al. Antidiabetic and antioxidant effect of methanol extract of Artanema sesamoides in streptozotocin-induced diabetic rats. Int J Appl Res Nat Prod 2008;1:25-33.
Gazanfar K, Ganai BA, Akbar S, Khan M, Dar SA, Dar MY, et al. Antidiabetic activity of Artemisia amygdalina decne in streptozotocin-induced diabetic rats. BioMed Res Int 2014;1-10. http://dx.doi.org/10.1155/2014/185676
Shulman GI. Cellular mechanism of insulin resistance. J Clin Invest 2000;106:171-6.
Setter SM, Iltz JL, Thams J, Campbell RK. Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy. Clin Ther 2003;25:2991-3026.
Castaneda C. Muscle wasting and protein metabolism. J Anim Sci 2002;80 Suppl 2:98-105.
Ramachandran S, Rajasekeran A, Adhiranjan N. In vivo and in-vitro antidiabetic activity of Terminalia paniculata barks: an evaluation of possible phytoconstituents and mechanisms for blood glucose control in diabetes. ISRN Pharmacol; 2013. p. 1-10.
Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and pathogenesis of insulin resistance. Physiol Rev 2007;87:507-20.
Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs 2013;73:327-39.
Reaven G, Abbasi F, McLaughlin. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004;59:207-23.
Rang HP, Dale MM, Ritter JM, Flower R, Henderson G. Rang and Dale’s Pharmacology. 8th ed. Churchill Livingstone: Philadelphia; 2015.
Zhang J, Yao Y, Yin J, Zhou Q, Xu W. Anti-diabetic effects of polysaccharides from Talium triangulare in streptozotocin (STZ)-induced type 2 diabetes male mice. Int J Biol Macromol 2015;72:575-9.
Rao GM, Morghom LO, Kabur MN, Ben Mohmud BN, Ashibani K. Serum glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) levels in diabetes mellitus. Indian J Med Sci 1989;43:118-21.
Harris EH. Elevated liver function tests in type 2 diabetes. Clin Diabetes 2005;23:115-9.
Gogoi B, Kakoti BB, Borah S, Borah SN. Antihyperglycemic and in vivo antioxidative activity evaluation of Cinnamomum bejolghota (Buch.-Ham.) in streptozotocin induced diabetic rats: an ethnomedicinal plant in Assam. Asian Pac J Trop Biomed 2014;7 Suppl 1:427-34.
Gaikward SB, Mohan GK, Rani MS. Phytochemicals for diabetes management. Pharm Crop 2014;5 Suppl 1:11-28.